Global Respiratory Disease Vaccine Market Growth 2026-2032
The global Respiratory Disease Vaccine market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
United States market for Respiratory Disease Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Respiratory Disease Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Respiratory Disease Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Respiratory Disease Vaccine players cover AstraZeneca, Emergent BioSolutions Inc., GSK plc., Johnson & Johnson Services, Inc., Merck & Co., Inc., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Respiratory Disease Vaccine Industry Forecast? looks at past sales and reviews total world Respiratory Disease Vaccine sales in 2025, providing a comprehensive analysis by region and market sector of projected Respiratory Disease Vaccine sales for 2026 through 2032. With Respiratory Disease Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Respiratory Disease Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Respiratory Disease Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Respiratory Disease Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Respiratory Disease Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Respiratory Disease Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Respiratory Disease Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of Respiratory Disease Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Respiratory Disease Vaccine market?
What factors are driving Respiratory Disease Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Respiratory Disease Vaccine market opportunities vary by end market size?
How does Respiratory Disease Vaccine break out by Type, by Application?
United States market for Respiratory Disease Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Respiratory Disease Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Respiratory Disease Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Respiratory Disease Vaccine players cover AstraZeneca, Emergent BioSolutions Inc., GSK plc., Johnson & Johnson Services, Inc., Merck & Co., Inc., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Respiratory Disease Vaccine Industry Forecast? looks at past sales and reviews total world Respiratory Disease Vaccine sales in 2025, providing a comprehensive analysis by region and market sector of projected Respiratory Disease Vaccine sales for 2026 through 2032. With Respiratory Disease Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Respiratory Disease Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Respiratory Disease Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Respiratory Disease Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Respiratory Disease Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Respiratory Disease Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Respiratory Disease Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of Respiratory Disease Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Live Attenuated
- Inactivated
- Others
- Flu
- Pneumonia
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- AstraZeneca
- Emergent BioSolutions Inc.
- GSK plc.
- Johnson & Johnson Services, Inc.
- Merck & Co., Inc.
- Novavax
- Pfizer Inc.
- Sanofi SA
- Serum Institute of India Pvt. Ltd.
- SINOVAC
What is the 10-year outlook for the global Respiratory Disease Vaccine market?
What factors are driving Respiratory Disease Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Respiratory Disease Vaccine market opportunities vary by end market size?
How does Respiratory Disease Vaccine break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Respiratory Disease Vaccine Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Respiratory Disease Vaccine by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Respiratory Disease Vaccine by Country/Region, 2021, 2025 & 2032
2.2 Respiratory Disease Vaccine Segment by Type
2.2.1 Live Attenuated
2.2.2 Inactivated
2.2.3 Others
2.2.4 Respiratory Disease Vaccine Sales by Type
2.2.4.1 Global Respiratory Disease Vaccine Sales Market Share by Type (2021-2026)
2.2.4.2 Global Respiratory Disease Vaccine Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Respiratory Disease Vaccine Sale Price by Type (2021-2026)
2.3 Respiratory Disease Vaccine Segment by Application
2.3.1 Flu
2.3.2 Pneumonia
2.3.3 Others
2.3.4 Respiratory Disease Vaccine Sales by Application
2.3.4.1 Global Respiratory Disease Vaccine Sale Market Share by Application (2021-2026)
2.3.4.2 Global Respiratory Disease Vaccine Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Respiratory Disease Vaccine Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Respiratory Disease Vaccine Breakdown Data by Company
3.1.1 Global Respiratory Disease Vaccine Annual Sales by Company (2021-2026)
3.1.2 Global Respiratory Disease Vaccine Sales Market Share by Company (2021-2026)
3.2 Global Respiratory Disease Vaccine Annual Revenue by Company (2021-2026)
3.2.1 Global Respiratory Disease Vaccine Revenue by Company (2021-2026)
3.2.2 Global Respiratory Disease Vaccine Revenue Market Share by Company (2021-2026)
3.3 Global Respiratory Disease Vaccine Sale Price by Company
3.4 Key Manufacturers Respiratory Disease Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Respiratory Disease Vaccine Product Location Distribution
3.4.2 Players Respiratory Disease Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR RESPIRATORY DISEASE VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Respiratory Disease Vaccine Market Size by Geographic Region (2021-2026)
4.1.1 Global Respiratory Disease Vaccine Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Respiratory Disease Vaccine Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Respiratory Disease Vaccine Market Size by Country/Region (2021-2026)
4.2.1 Global Respiratory Disease Vaccine Annual Sales by Country/Region (2021-2026)
4.2.2 Global Respiratory Disease Vaccine Annual Revenue by Country/Region (2021-2026)
4.3 Americas Respiratory Disease Vaccine Sales Growth
4.4 APAC Respiratory Disease Vaccine Sales Growth
4.5 Europe Respiratory Disease Vaccine Sales Growth
4.6 Middle East & Africa Respiratory Disease Vaccine Sales Growth
5 AMERICAS
5.1 Americas Respiratory Disease Vaccine Sales by Country
5.1.1 Americas Respiratory Disease Vaccine Sales by Country (2021-2026)
5.1.2 Americas Respiratory Disease Vaccine Revenue by Country (2021-2026)
5.2 Americas Respiratory Disease Vaccine Sales by Type (2021-2026)
5.3 Americas Respiratory Disease Vaccine Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Respiratory Disease Vaccine Sales by Region
6.1.1 APAC Respiratory Disease Vaccine Sales by Region (2021-2026)
6.1.2 APAC Respiratory Disease Vaccine Revenue by Region (2021-2026)
6.2 APAC Respiratory Disease Vaccine Sales by Type (2021-2026)
6.3 APAC Respiratory Disease Vaccine Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Respiratory Disease Vaccine by Country
7.1.1 Europe Respiratory Disease Vaccine Sales by Country (2021-2026)
7.1.2 Europe Respiratory Disease Vaccine Revenue by Country (2021-2026)
7.2 Europe Respiratory Disease Vaccine Sales by Type (2021-2026)
7.3 Europe Respiratory Disease Vaccine Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Respiratory Disease Vaccine by Country
8.1.1 Middle East & Africa Respiratory Disease Vaccine Sales by Country (2021-2026)
8.1.2 Middle East & Africa Respiratory Disease Vaccine Revenue by Country (2021-2026)
8.2 Middle East & Africa Respiratory Disease Vaccine Sales by Type (2021-2026)
8.3 Middle East & Africa Respiratory Disease Vaccine Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Respiratory Disease Vaccine
10.3 Manufacturing Process Analysis of Respiratory Disease Vaccine
10.4 Industry Chain Structure of Respiratory Disease Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Respiratory Disease Vaccine Distributors
11.3 Respiratory Disease Vaccine Customer
12 WORLD FORECAST REVIEW FOR RESPIRATORY DISEASE VACCINE BY GEOGRAPHIC REGION
12.1 Global Respiratory Disease Vaccine Market Size Forecast by Region
12.1.1 Global Respiratory Disease Vaccine Forecast by Region (2027-2032)
12.1.2 Global Respiratory Disease Vaccine Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Respiratory Disease Vaccine Forecast by Type (2027-2032)
12.7 Global Respiratory Disease Vaccine Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 AstraZeneca
13.1.1 AstraZeneca Company Information
13.1.2 AstraZeneca Respiratory Disease Vaccine Product Portfolios and Specifications
13.1.3 AstraZeneca Respiratory Disease Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 AstraZeneca Main Business Overview
13.1.5 AstraZeneca Latest Developments
13.2 Emergent BioSolutions Inc.
13.2.1 Emergent BioSolutions Inc. Company Information
13.2.2 Emergent BioSolutions Inc. Respiratory Disease Vaccine Product Portfolios and Specifications
13.2.3 Emergent BioSolutions Inc. Respiratory Disease Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Emergent BioSolutions Inc. Main Business Overview
13.2.5 Emergent BioSolutions Inc. Latest Developments
13.3 GSK plc.
13.3.1 GSK plc. Company Information
13.3.2 GSK plc. Respiratory Disease Vaccine Product Portfolios and Specifications
13.3.3 GSK plc. Respiratory Disease Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 GSK plc. Main Business Overview
13.3.5 GSK plc. Latest Developments
13.4 Johnson & Johnson Services, Inc.
13.4.1 Johnson & Johnson Services, Inc. Company Information
13.4.2 Johnson & Johnson Services, Inc. Respiratory Disease Vaccine Product Portfolios and Specifications
13.4.3 Johnson & Johnson Services, Inc. Respiratory Disease Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Johnson & Johnson Services, Inc. Main Business Overview
13.4.5 Johnson & Johnson Services, Inc. Latest Developments
13.5 Merck & Co., Inc.
13.5.1 Merck & Co., Inc. Company Information
13.5.2 Merck & Co., Inc. Respiratory Disease Vaccine Product Portfolios and Specifications
13.5.3 Merck & Co., Inc. Respiratory Disease Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Merck & Co., Inc. Main Business Overview
13.5.5 Merck & Co., Inc. Latest Developments
13.6 Novavax
13.6.1 Novavax Company Information
13.6.2 Novavax Respiratory Disease Vaccine Product Portfolios and Specifications
13.6.3 Novavax Respiratory Disease Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Novavax Main Business Overview
13.6.5 Novavax Latest Developments
13.7 Pfizer Inc.
13.7.1 Pfizer Inc. Company Information
13.7.2 Pfizer Inc. Respiratory Disease Vaccine Product Portfolios and Specifications
13.7.3 Pfizer Inc. Respiratory Disease Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Pfizer Inc. Main Business Overview
13.7.5 Pfizer Inc. Latest Developments
13.8 Sanofi SA
13.8.1 Sanofi SA Company Information
13.8.2 Sanofi SA Respiratory Disease Vaccine Product Portfolios and Specifications
13.8.3 Sanofi SA Respiratory Disease Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Sanofi SA Main Business Overview
13.8.5 Sanofi SA Latest Developments
13.9 Serum Institute of India Pvt. Ltd.
13.9.1 Serum Institute of India Pvt. Ltd. Company Information
13.9.2 Serum Institute of India Pvt. Ltd. Respiratory Disease Vaccine Product Portfolios and Specifications
13.9.3 Serum Institute of India Pvt. Ltd. Respiratory Disease Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Serum Institute of India Pvt. Ltd. Main Business Overview
13.9.5 Serum Institute of India Pvt. Ltd. Latest Developments
13.10 SINOVAC
13.10.1 SINOVAC Company Information
13.10.2 SINOVAC Respiratory Disease Vaccine Product Portfolios and Specifications
13.10.3 SINOVAC Respiratory Disease Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 SINOVAC Main Business Overview
13.10.5 SINOVAC Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Respiratory Disease Vaccine Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Respiratory Disease Vaccine by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Respiratory Disease Vaccine by Country/Region, 2021, 2025 & 2032
2.2 Respiratory Disease Vaccine Segment by Type
2.2.1 Live Attenuated
2.2.2 Inactivated
2.2.3 Others
2.2.4 Respiratory Disease Vaccine Sales by Type
2.2.4.1 Global Respiratory Disease Vaccine Sales Market Share by Type (2021-2026)
2.2.4.2 Global Respiratory Disease Vaccine Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Respiratory Disease Vaccine Sale Price by Type (2021-2026)
2.3 Respiratory Disease Vaccine Segment by Application
2.3.1 Flu
2.3.2 Pneumonia
2.3.3 Others
2.3.4 Respiratory Disease Vaccine Sales by Application
2.3.4.1 Global Respiratory Disease Vaccine Sale Market Share by Application (2021-2026)
2.3.4.2 Global Respiratory Disease Vaccine Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Respiratory Disease Vaccine Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Respiratory Disease Vaccine Breakdown Data by Company
3.1.1 Global Respiratory Disease Vaccine Annual Sales by Company (2021-2026)
3.1.2 Global Respiratory Disease Vaccine Sales Market Share by Company (2021-2026)
3.2 Global Respiratory Disease Vaccine Annual Revenue by Company (2021-2026)
3.2.1 Global Respiratory Disease Vaccine Revenue by Company (2021-2026)
3.2.2 Global Respiratory Disease Vaccine Revenue Market Share by Company (2021-2026)
3.3 Global Respiratory Disease Vaccine Sale Price by Company
3.4 Key Manufacturers Respiratory Disease Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Respiratory Disease Vaccine Product Location Distribution
3.4.2 Players Respiratory Disease Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR RESPIRATORY DISEASE VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Respiratory Disease Vaccine Market Size by Geographic Region (2021-2026)
4.1.1 Global Respiratory Disease Vaccine Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Respiratory Disease Vaccine Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Respiratory Disease Vaccine Market Size by Country/Region (2021-2026)
4.2.1 Global Respiratory Disease Vaccine Annual Sales by Country/Region (2021-2026)
4.2.2 Global Respiratory Disease Vaccine Annual Revenue by Country/Region (2021-2026)
4.3 Americas Respiratory Disease Vaccine Sales Growth
4.4 APAC Respiratory Disease Vaccine Sales Growth
4.5 Europe Respiratory Disease Vaccine Sales Growth
4.6 Middle East & Africa Respiratory Disease Vaccine Sales Growth
5 AMERICAS
5.1 Americas Respiratory Disease Vaccine Sales by Country
5.1.1 Americas Respiratory Disease Vaccine Sales by Country (2021-2026)
5.1.2 Americas Respiratory Disease Vaccine Revenue by Country (2021-2026)
5.2 Americas Respiratory Disease Vaccine Sales by Type (2021-2026)
5.3 Americas Respiratory Disease Vaccine Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Respiratory Disease Vaccine Sales by Region
6.1.1 APAC Respiratory Disease Vaccine Sales by Region (2021-2026)
6.1.2 APAC Respiratory Disease Vaccine Revenue by Region (2021-2026)
6.2 APAC Respiratory Disease Vaccine Sales by Type (2021-2026)
6.3 APAC Respiratory Disease Vaccine Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Respiratory Disease Vaccine by Country
7.1.1 Europe Respiratory Disease Vaccine Sales by Country (2021-2026)
7.1.2 Europe Respiratory Disease Vaccine Revenue by Country (2021-2026)
7.2 Europe Respiratory Disease Vaccine Sales by Type (2021-2026)
7.3 Europe Respiratory Disease Vaccine Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Respiratory Disease Vaccine by Country
8.1.1 Middle East & Africa Respiratory Disease Vaccine Sales by Country (2021-2026)
8.1.2 Middle East & Africa Respiratory Disease Vaccine Revenue by Country (2021-2026)
8.2 Middle East & Africa Respiratory Disease Vaccine Sales by Type (2021-2026)
8.3 Middle East & Africa Respiratory Disease Vaccine Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Respiratory Disease Vaccine
10.3 Manufacturing Process Analysis of Respiratory Disease Vaccine
10.4 Industry Chain Structure of Respiratory Disease Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Respiratory Disease Vaccine Distributors
11.3 Respiratory Disease Vaccine Customer
12 WORLD FORECAST REVIEW FOR RESPIRATORY DISEASE VACCINE BY GEOGRAPHIC REGION
12.1 Global Respiratory Disease Vaccine Market Size Forecast by Region
12.1.1 Global Respiratory Disease Vaccine Forecast by Region (2027-2032)
12.1.2 Global Respiratory Disease Vaccine Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Respiratory Disease Vaccine Forecast by Type (2027-2032)
12.7 Global Respiratory Disease Vaccine Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 AstraZeneca
13.1.1 AstraZeneca Company Information
13.1.2 AstraZeneca Respiratory Disease Vaccine Product Portfolios and Specifications
13.1.3 AstraZeneca Respiratory Disease Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 AstraZeneca Main Business Overview
13.1.5 AstraZeneca Latest Developments
13.2 Emergent BioSolutions Inc.
13.2.1 Emergent BioSolutions Inc. Company Information
13.2.2 Emergent BioSolutions Inc. Respiratory Disease Vaccine Product Portfolios and Specifications
13.2.3 Emergent BioSolutions Inc. Respiratory Disease Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Emergent BioSolutions Inc. Main Business Overview
13.2.5 Emergent BioSolutions Inc. Latest Developments
13.3 GSK plc.
13.3.1 GSK plc. Company Information
13.3.2 GSK plc. Respiratory Disease Vaccine Product Portfolios and Specifications
13.3.3 GSK plc. Respiratory Disease Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 GSK plc. Main Business Overview
13.3.5 GSK plc. Latest Developments
13.4 Johnson & Johnson Services, Inc.
13.4.1 Johnson & Johnson Services, Inc. Company Information
13.4.2 Johnson & Johnson Services, Inc. Respiratory Disease Vaccine Product Portfolios and Specifications
13.4.3 Johnson & Johnson Services, Inc. Respiratory Disease Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Johnson & Johnson Services, Inc. Main Business Overview
13.4.5 Johnson & Johnson Services, Inc. Latest Developments
13.5 Merck & Co., Inc.
13.5.1 Merck & Co., Inc. Company Information
13.5.2 Merck & Co., Inc. Respiratory Disease Vaccine Product Portfolios and Specifications
13.5.3 Merck & Co., Inc. Respiratory Disease Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Merck & Co., Inc. Main Business Overview
13.5.5 Merck & Co., Inc. Latest Developments
13.6 Novavax
13.6.1 Novavax Company Information
13.6.2 Novavax Respiratory Disease Vaccine Product Portfolios and Specifications
13.6.3 Novavax Respiratory Disease Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Novavax Main Business Overview
13.6.5 Novavax Latest Developments
13.7 Pfizer Inc.
13.7.1 Pfizer Inc. Company Information
13.7.2 Pfizer Inc. Respiratory Disease Vaccine Product Portfolios and Specifications
13.7.3 Pfizer Inc. Respiratory Disease Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Pfizer Inc. Main Business Overview
13.7.5 Pfizer Inc. Latest Developments
13.8 Sanofi SA
13.8.1 Sanofi SA Company Information
13.8.2 Sanofi SA Respiratory Disease Vaccine Product Portfolios and Specifications
13.8.3 Sanofi SA Respiratory Disease Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Sanofi SA Main Business Overview
13.8.5 Sanofi SA Latest Developments
13.9 Serum Institute of India Pvt. Ltd.
13.9.1 Serum Institute of India Pvt. Ltd. Company Information
13.9.2 Serum Institute of India Pvt. Ltd. Respiratory Disease Vaccine Product Portfolios and Specifications
13.9.3 Serum Institute of India Pvt. Ltd. Respiratory Disease Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Serum Institute of India Pvt. Ltd. Main Business Overview
13.9.5 Serum Institute of India Pvt. Ltd. Latest Developments
13.10 SINOVAC
13.10.1 SINOVAC Company Information
13.10.2 SINOVAC Respiratory Disease Vaccine Product Portfolios and Specifications
13.10.3 SINOVAC Respiratory Disease Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 SINOVAC Main Business Overview
13.10.5 SINOVAC Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Respiratory Disease Vaccine Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Respiratory Disease Vaccine Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Live Attenuated
Table 4. Major Players of Inactivated
Table 5. Major Players of Others
Table 6. Global Respiratory Disease Vaccine Sales by Type (2021-2026) & (K Units)
Table 7. Global Respiratory Disease Vaccine Sales Market Share by Type (2021-2026)
Table 8. Global Respiratory Disease Vaccine Revenue by Type (2021-2026) & ($ million)
Table 9. Global Respiratory Disease Vaccine Revenue Market Share by Type (2021-2026)
Table 10. Global Respiratory Disease Vaccine Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Global Respiratory Disease Vaccine Sale by Application (2021-2026) & (K Units)
Table 12. Global Respiratory Disease Vaccine Sale Market Share by Application (2021-2026)
Table 13. Global Respiratory Disease Vaccine Revenue by Application (2021-2026) & ($ million)
Table 14. Global Respiratory Disease Vaccine Revenue Market Share by Application (2021-2026)
Table 15. Global Respiratory Disease Vaccine Sale Price by Application (2021-2026) & (US$/Unit)
Table 16. Global Respiratory Disease Vaccine Sales by Company (2021-2026) & (K Units)
Table 17. Global Respiratory Disease Vaccine Sales Market Share by Company (2021-2026)
Table 18. Global Respiratory Disease Vaccine Revenue by Company (2021-2026) & ($ millions)
Table 19. Global Respiratory Disease Vaccine Revenue Market Share by Company (2021-2026)
Table 20. Global Respiratory Disease Vaccine Sale Price by Company (2021-2026) & (US$/Unit)
Table 21. Key Manufacturers Respiratory Disease Vaccine Producing Area Distribution and Sales Area
Table 22. Players Respiratory Disease Vaccine Products Offered
Table 23. Respiratory Disease Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Respiratory Disease Vaccine Sales by Geographic Region (2021-2026) & (K Units)
Table 27. Global Respiratory Disease Vaccine Sales Market Share Geographic Region (2021-2026)
Table 28. Global Respiratory Disease Vaccine Revenue by Geographic Region (2021-2026) & ($ millions)
Table 29. Global Respiratory Disease Vaccine Revenue Market Share by Geographic Region (2021-2026)
Table 30. Global Respiratory Disease Vaccine Sales by Country/Region (2021-2026) & (K Units)
Table 31. Global Respiratory Disease Vaccine Sales Market Share by Country/Region (2021-2026)
Table 32. Global Respiratory Disease Vaccine Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global Respiratory Disease Vaccine Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas Respiratory Disease Vaccine Sales by Country (2021-2026) & (K Units)
Table 35. Americas Respiratory Disease Vaccine Sales Market Share by Country (2021-2026)
Table 36. Americas Respiratory Disease Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 37. Americas Respiratory Disease Vaccine Sales by Type (2021-2026) & (K Units)
Table 38. Americas Respiratory Disease Vaccine Sales by Application (2021-2026) & (K Units)
Table 39. APAC Respiratory Disease Vaccine Sales by Region (2021-2026) & (K Units)
Table 40. APAC Respiratory Disease Vaccine Sales Market Share by Region (2021-2026)
Table 41. APAC Respiratory Disease Vaccine Revenue by Region (2021-2026) & ($ millions)
Table 42. APAC Respiratory Disease Vaccine Sales by Type (2021-2026) & (K Units)
Table 43. APAC Respiratory Disease Vaccine Sales by Application (2021-2026) & (K Units)
Table 44. Europe Respiratory Disease Vaccine Sales by Country (2021-2026) & (K Units)
Table 45. Europe Respiratory Disease Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 46. Europe Respiratory Disease Vaccine Sales by Type (2021-2026) & (K Units)
Table 47. Europe Respiratory Disease Vaccine Sales by Application (2021-2026) & (K Units)
Table 48. Middle East & Africa Respiratory Disease Vaccine Sales by Country (2021-2026) & (K Units)
Table 49. Middle East & Africa Respiratory Disease Vaccine Revenue Market Share by Country (2021-2026)
Table 50. Middle East & Africa Respiratory Disease Vaccine Sales by Type (2021-2026) & (K Units)
Table 51. Middle East & Africa Respiratory Disease Vaccine Sales by Application (2021-2026) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Respiratory Disease Vaccine
Table 53. Key Market Challenges & Risks of Respiratory Disease Vaccine
Table 54. Key Industry Trends of Respiratory Disease Vaccine
Table 55. Respiratory Disease Vaccine Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Respiratory Disease Vaccine Distributors List
Table 58. Respiratory Disease Vaccine Customer List
Table 59. Global Respiratory Disease Vaccine Sales Forecast by Region (2027-2032) & (K Units)
Table 60. Global Respiratory Disease Vaccine Revenue Forecast by Region (2027-2032) & ($ millions)
Table 61. Americas Respiratory Disease Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 62. Americas Respiratory Disease Vaccine Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 63. APAC Respiratory Disease Vaccine Sales Forecast by Region (2027-2032) & (K Units)
Table 64. APAC Respiratory Disease Vaccine Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 65. Europe Respiratory Disease Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 66. Europe Respiratory Disease Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 67. Middle East & Africa Respiratory Disease Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 68. Middle East & Africa Respiratory Disease Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Global Respiratory Disease Vaccine Sales Forecast by Type (2027-2032) & (K Units)
Table 70. Global Respiratory Disease Vaccine Revenue Forecast by Type (2027-2032) & ($ millions)
Table 71. Global Respiratory Disease Vaccine Sales Forecast by Application (2027-2032) & (K Units)
Table 72. Global Respiratory Disease Vaccine Revenue Forecast by Application (2027-2032) & ($ millions)
Table 73. AstraZeneca Basic Information, Respiratory Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 74. AstraZeneca Respiratory Disease Vaccine Product Portfolios and Specifications
Table 75. AstraZeneca Respiratory Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 76. AstraZeneca Main Business
Table 77. AstraZeneca Latest Developments
Table 78. Emergent BioSolutions Inc. Basic Information, Respiratory Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 79. Emergent BioSolutions Inc. Respiratory Disease Vaccine Product Portfolios and Specifications
Table 80. Emergent BioSolutions Inc. Respiratory Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 81. Emergent BioSolutions Inc. Main Business
Table 82. Emergent BioSolutions Inc. Latest Developments
Table 83. GSK plc. Basic Information, Respiratory Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 84. GSK plc. Respiratory Disease Vaccine Product Portfolios and Specifications
Table 85. GSK plc. Respiratory Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 86. GSK plc. Main Business
Table 87. GSK plc. Latest Developments
Table 88. Johnson & Johnson Services, Inc. Basic Information, Respiratory Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 89. Johnson & Johnson Services, Inc. Respiratory Disease Vaccine Product Portfolios and Specifications
Table 90. Johnson & Johnson Services, Inc. Respiratory Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. Johnson & Johnson Services, Inc. Main Business
Table 92. Johnson & Johnson Services, Inc. Latest Developments
Table 93. Merck & Co., Inc. Basic Information, Respiratory Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 94. Merck & Co., Inc. Respiratory Disease Vaccine Product Portfolios and Specifications
Table 95. Merck & Co., Inc. Respiratory Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. Merck & Co., Inc. Main Business
Table 97. Merck & Co., Inc. Latest Developments
Table 98. Novavax Basic Information, Respiratory Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 99. Novavax Respiratory Disease Vaccine Product Portfolios and Specifications
Table 100. Novavax Respiratory Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. Novavax Main Business
Table 102. Novavax Latest Developments
Table 103. Pfizer Inc. Basic Information, Respiratory Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 104. Pfizer Inc. Respiratory Disease Vaccine Product Portfolios and Specifications
Table 105. Pfizer Inc. Respiratory Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. Pfizer Inc. Main Business
Table 107. Pfizer Inc. Latest Developments
Table 108. Sanofi SA Basic Information, Respiratory Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 109. Sanofi SA Respiratory Disease Vaccine Product Portfolios and Specifications
Table 110. Sanofi SA Respiratory Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. Sanofi SA Main Business
Table 112. Sanofi SA Latest Developments
Table 113. Serum Institute of India Pvt. Ltd. Basic Information, Respiratory Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 114. Serum Institute of India Pvt. Ltd. Respiratory Disease Vaccine Product Portfolios and Specifications
Table 115. Serum Institute of India Pvt. Ltd. Respiratory Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. Serum Institute of India Pvt. Ltd. Main Business
Table 117. Serum Institute of India Pvt. Ltd. Latest Developments
Table 118. SINOVAC Basic Information, Respiratory Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 119. SINOVAC Respiratory Disease Vaccine Product Portfolios and Specifications
Table 120. SINOVAC Respiratory Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 121. SINOVAC Main Business
Table 122. SINOVAC Latest Developments
Table 1. Respiratory Disease Vaccine Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Respiratory Disease Vaccine Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Live Attenuated
Table 4. Major Players of Inactivated
Table 5. Major Players of Others
Table 6. Global Respiratory Disease Vaccine Sales by Type (2021-2026) & (K Units)
Table 7. Global Respiratory Disease Vaccine Sales Market Share by Type (2021-2026)
Table 8. Global Respiratory Disease Vaccine Revenue by Type (2021-2026) & ($ million)
Table 9. Global Respiratory Disease Vaccine Revenue Market Share by Type (2021-2026)
Table 10. Global Respiratory Disease Vaccine Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Global Respiratory Disease Vaccine Sale by Application (2021-2026) & (K Units)
Table 12. Global Respiratory Disease Vaccine Sale Market Share by Application (2021-2026)
Table 13. Global Respiratory Disease Vaccine Revenue by Application (2021-2026) & ($ million)
Table 14. Global Respiratory Disease Vaccine Revenue Market Share by Application (2021-2026)
Table 15. Global Respiratory Disease Vaccine Sale Price by Application (2021-2026) & (US$/Unit)
Table 16. Global Respiratory Disease Vaccine Sales by Company (2021-2026) & (K Units)
Table 17. Global Respiratory Disease Vaccine Sales Market Share by Company (2021-2026)
Table 18. Global Respiratory Disease Vaccine Revenue by Company (2021-2026) & ($ millions)
Table 19. Global Respiratory Disease Vaccine Revenue Market Share by Company (2021-2026)
Table 20. Global Respiratory Disease Vaccine Sale Price by Company (2021-2026) & (US$/Unit)
Table 21. Key Manufacturers Respiratory Disease Vaccine Producing Area Distribution and Sales Area
Table 22. Players Respiratory Disease Vaccine Products Offered
Table 23. Respiratory Disease Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Respiratory Disease Vaccine Sales by Geographic Region (2021-2026) & (K Units)
Table 27. Global Respiratory Disease Vaccine Sales Market Share Geographic Region (2021-2026)
Table 28. Global Respiratory Disease Vaccine Revenue by Geographic Region (2021-2026) & ($ millions)
Table 29. Global Respiratory Disease Vaccine Revenue Market Share by Geographic Region (2021-2026)
Table 30. Global Respiratory Disease Vaccine Sales by Country/Region (2021-2026) & (K Units)
Table 31. Global Respiratory Disease Vaccine Sales Market Share by Country/Region (2021-2026)
Table 32. Global Respiratory Disease Vaccine Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global Respiratory Disease Vaccine Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas Respiratory Disease Vaccine Sales by Country (2021-2026) & (K Units)
Table 35. Americas Respiratory Disease Vaccine Sales Market Share by Country (2021-2026)
Table 36. Americas Respiratory Disease Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 37. Americas Respiratory Disease Vaccine Sales by Type (2021-2026) & (K Units)
Table 38. Americas Respiratory Disease Vaccine Sales by Application (2021-2026) & (K Units)
Table 39. APAC Respiratory Disease Vaccine Sales by Region (2021-2026) & (K Units)
Table 40. APAC Respiratory Disease Vaccine Sales Market Share by Region (2021-2026)
Table 41. APAC Respiratory Disease Vaccine Revenue by Region (2021-2026) & ($ millions)
Table 42. APAC Respiratory Disease Vaccine Sales by Type (2021-2026) & (K Units)
Table 43. APAC Respiratory Disease Vaccine Sales by Application (2021-2026) & (K Units)
Table 44. Europe Respiratory Disease Vaccine Sales by Country (2021-2026) & (K Units)
Table 45. Europe Respiratory Disease Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 46. Europe Respiratory Disease Vaccine Sales by Type (2021-2026) & (K Units)
Table 47. Europe Respiratory Disease Vaccine Sales by Application (2021-2026) & (K Units)
Table 48. Middle East & Africa Respiratory Disease Vaccine Sales by Country (2021-2026) & (K Units)
Table 49. Middle East & Africa Respiratory Disease Vaccine Revenue Market Share by Country (2021-2026)
Table 50. Middle East & Africa Respiratory Disease Vaccine Sales by Type (2021-2026) & (K Units)
Table 51. Middle East & Africa Respiratory Disease Vaccine Sales by Application (2021-2026) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Respiratory Disease Vaccine
Table 53. Key Market Challenges & Risks of Respiratory Disease Vaccine
Table 54. Key Industry Trends of Respiratory Disease Vaccine
Table 55. Respiratory Disease Vaccine Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Respiratory Disease Vaccine Distributors List
Table 58. Respiratory Disease Vaccine Customer List
Table 59. Global Respiratory Disease Vaccine Sales Forecast by Region (2027-2032) & (K Units)
Table 60. Global Respiratory Disease Vaccine Revenue Forecast by Region (2027-2032) & ($ millions)
Table 61. Americas Respiratory Disease Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 62. Americas Respiratory Disease Vaccine Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 63. APAC Respiratory Disease Vaccine Sales Forecast by Region (2027-2032) & (K Units)
Table 64. APAC Respiratory Disease Vaccine Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 65. Europe Respiratory Disease Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 66. Europe Respiratory Disease Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 67. Middle East & Africa Respiratory Disease Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 68. Middle East & Africa Respiratory Disease Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Global Respiratory Disease Vaccine Sales Forecast by Type (2027-2032) & (K Units)
Table 70. Global Respiratory Disease Vaccine Revenue Forecast by Type (2027-2032) & ($ millions)
Table 71. Global Respiratory Disease Vaccine Sales Forecast by Application (2027-2032) & (K Units)
Table 72. Global Respiratory Disease Vaccine Revenue Forecast by Application (2027-2032) & ($ millions)
Table 73. AstraZeneca Basic Information, Respiratory Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 74. AstraZeneca Respiratory Disease Vaccine Product Portfolios and Specifications
Table 75. AstraZeneca Respiratory Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 76. AstraZeneca Main Business
Table 77. AstraZeneca Latest Developments
Table 78. Emergent BioSolutions Inc. Basic Information, Respiratory Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 79. Emergent BioSolutions Inc. Respiratory Disease Vaccine Product Portfolios and Specifications
Table 80. Emergent BioSolutions Inc. Respiratory Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 81. Emergent BioSolutions Inc. Main Business
Table 82. Emergent BioSolutions Inc. Latest Developments
Table 83. GSK plc. Basic Information, Respiratory Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 84. GSK plc. Respiratory Disease Vaccine Product Portfolios and Specifications
Table 85. GSK plc. Respiratory Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 86. GSK plc. Main Business
Table 87. GSK plc. Latest Developments
Table 88. Johnson & Johnson Services, Inc. Basic Information, Respiratory Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 89. Johnson & Johnson Services, Inc. Respiratory Disease Vaccine Product Portfolios and Specifications
Table 90. Johnson & Johnson Services, Inc. Respiratory Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. Johnson & Johnson Services, Inc. Main Business
Table 92. Johnson & Johnson Services, Inc. Latest Developments
Table 93. Merck & Co., Inc. Basic Information, Respiratory Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 94. Merck & Co., Inc. Respiratory Disease Vaccine Product Portfolios and Specifications
Table 95. Merck & Co., Inc. Respiratory Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. Merck & Co., Inc. Main Business
Table 97. Merck & Co., Inc. Latest Developments
Table 98. Novavax Basic Information, Respiratory Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 99. Novavax Respiratory Disease Vaccine Product Portfolios and Specifications
Table 100. Novavax Respiratory Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. Novavax Main Business
Table 102. Novavax Latest Developments
Table 103. Pfizer Inc. Basic Information, Respiratory Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 104. Pfizer Inc. Respiratory Disease Vaccine Product Portfolios and Specifications
Table 105. Pfizer Inc. Respiratory Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. Pfizer Inc. Main Business
Table 107. Pfizer Inc. Latest Developments
Table 108. Sanofi SA Basic Information, Respiratory Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 109. Sanofi SA Respiratory Disease Vaccine Product Portfolios and Specifications
Table 110. Sanofi SA Respiratory Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. Sanofi SA Main Business
Table 112. Sanofi SA Latest Developments
Table 113. Serum Institute of India Pvt. Ltd. Basic Information, Respiratory Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 114. Serum Institute of India Pvt. Ltd. Respiratory Disease Vaccine Product Portfolios and Specifications
Table 115. Serum Institute of India Pvt. Ltd. Respiratory Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. Serum Institute of India Pvt. Ltd. Main Business
Table 117. Serum Institute of India Pvt. Ltd. Latest Developments
Table 118. SINOVAC Basic Information, Respiratory Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 119. SINOVAC Respiratory Disease Vaccine Product Portfolios and Specifications
Table 120. SINOVAC Respiratory Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 121. SINOVAC Main Business
Table 122. SINOVAC Latest Developments
LIST OF FIGURES
Figure 1. Picture of Respiratory Disease Vaccine
Figure 2. Respiratory Disease Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Respiratory Disease Vaccine Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Respiratory Disease Vaccine Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Respiratory Disease Vaccine Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Respiratory Disease Vaccine Sales Market Share by Country/Region (2025)
Figure 10. Respiratory Disease Vaccine Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Live Attenuated
Figure 12. Product Picture of Inactivated
Figure 13. Product Picture of Others
Figure 14. Global Respiratory Disease Vaccine Sales Market Share by Type in 2026
Figure 15. Global Respiratory Disease Vaccine Revenue Market Share by Type (2021-2026)
Figure 16. Respiratory Disease Vaccine Consumed in Flu
Figure 17. Global Respiratory Disease Vaccine Market: Flu (2021-2026) & (K Units)
Figure 18. Respiratory Disease Vaccine Consumed in Pneumonia
Figure 19. Global Respiratory Disease Vaccine Market: Pneumonia (2021-2026) & (K Units)
Figure 20. Respiratory Disease Vaccine Consumed in Others
Figure 21. Global Respiratory Disease Vaccine Market: Others (2021-2026) & (K Units)
Figure 22. Global Respiratory Disease Vaccine Sale Market Share by Application (2025)
Figure 23. Global Respiratory Disease Vaccine Revenue Market Share by Application in 2026
Figure 24. Respiratory Disease Vaccine Sales by Company in 2026 (K Units)
Figure 25. Global Respiratory Disease Vaccine Sales Market Share by Company in 2026
Figure 26. Respiratory Disease Vaccine Revenue by Company in 2026 ($ millions)
Figure 27. Global Respiratory Disease Vaccine Revenue Market Share by Company in 2026
Figure 28. Global Respiratory Disease Vaccine Sales Market Share by Geographic Region (2021-2026)
Figure 29. Global Respiratory Disease Vaccine Revenue Market Share by Geographic Region in 2026
Figure 30. Americas Respiratory Disease Vaccine Sales 2021-2026 (K Units)
Figure 31. Americas Respiratory Disease Vaccine Revenue 2021-2026 ($ millions)
Figure 32. APAC Respiratory Disease Vaccine Sales 2021-2026 (K Units)
Figure 33. APAC Respiratory Disease Vaccine Revenue 2021-2026 ($ millions)
Figure 34. Europe Respiratory Disease Vaccine Sales 2021-2026 (K Units)
Figure 35. Europe Respiratory Disease Vaccine Revenue 2021-2026 ($ millions)
Figure 36. Middle East & Africa Respiratory Disease Vaccine Sales 2021-2026 (K Units)
Figure 37. Middle East & Africa Respiratory Disease Vaccine Revenue 2021-2026 ($ millions)
Figure 38. Americas Respiratory Disease Vaccine Sales Market Share by Country in 2026
Figure 39. Americas Respiratory Disease Vaccine Revenue Market Share by Country (2021-2026)
Figure 40. Americas Respiratory Disease Vaccine Sales Market Share by Type (2021-2026)
Figure 41. Americas Respiratory Disease Vaccine Sales Market Share by Application (2021-2026)
Figure 42. United States Respiratory Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 43. Canada Respiratory Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 44. Mexico Respiratory Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 45. Brazil Respiratory Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 46. APAC Respiratory Disease Vaccine Sales Market Share by Region in 2026
Figure 47. APAC Respiratory Disease Vaccine Revenue Market Share by Region (2021-2026)
Figure 48. APAC Respiratory Disease Vaccine Sales Market Share by Type (2021-2026)
Figure 49. APAC Respiratory Disease Vaccine Sales Market Share by Application (2021-2026)
Figure 50. China Respiratory Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 51. Japan Respiratory Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 52. South Korea Respiratory Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 53. Southeast Asia Respiratory Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 54. India Respiratory Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 55. Australia Respiratory Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 56. China Taiwan Respiratory Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 57. Europe Respiratory Disease Vaccine Sales Market Share by Country in 2026
Figure 58. Europe Respiratory Disease Vaccine Revenue Market Share by Country (2021-2026)
Figure 59. Europe Respiratory Disease Vaccine Sales Market Share by Type (2021-2026)
Figure 60. Europe Respiratory Disease Vaccine Sales Market Share by Application (2021-2026)
Figure 61. Germany Respiratory Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 62. France Respiratory Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 63. UK Respiratory Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 64. Italy Respiratory Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 65. Russia Respiratory Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 66. Middle East & Africa Respiratory Disease Vaccine Sales Market Share by Country (2021-2026)
Figure 67. Middle East & Africa Respiratory Disease Vaccine Sales Market Share by Type (2021-2026)
Figure 68. Middle East & Africa Respiratory Disease Vaccine Sales Market Share by Application (2021-2026)
Figure 69. Egypt Respiratory Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 70. South Africa Respiratory Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 71. Israel Respiratory Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 72. Turkey Respiratory Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 73. GCC Countries Respiratory Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Respiratory Disease Vaccine in 2026
Figure 75. Manufacturing Process Analysis of Respiratory Disease Vaccine
Figure 76. Industry Chain Structure of Respiratory Disease Vaccine
Figure 77. Channels of Distribution
Figure 78. Global Respiratory Disease Vaccine Sales Market Forecast by Region (2027-2032)
Figure 79. Global Respiratory Disease Vaccine Revenue Market Share Forecast by Region (2027-2032)
Figure 80. Global Respiratory Disease Vaccine Sales Market Share Forecast by Type (2027-2032)
Figure 81. Global Respiratory Disease Vaccine Revenue Market Share Forecast by Type (2027-2032)
Figure 82. Global Respiratory Disease Vaccine Sales Market Share Forecast by Application (2027-2032)
Figure 83. Global Respiratory Disease Vaccine Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Respiratory Disease Vaccine
Figure 2. Respiratory Disease Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Respiratory Disease Vaccine Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Respiratory Disease Vaccine Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Respiratory Disease Vaccine Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Respiratory Disease Vaccine Sales Market Share by Country/Region (2025)
Figure 10. Respiratory Disease Vaccine Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Live Attenuated
Figure 12. Product Picture of Inactivated
Figure 13. Product Picture of Others
Figure 14. Global Respiratory Disease Vaccine Sales Market Share by Type in 2026
Figure 15. Global Respiratory Disease Vaccine Revenue Market Share by Type (2021-2026)
Figure 16. Respiratory Disease Vaccine Consumed in Flu
Figure 17. Global Respiratory Disease Vaccine Market: Flu (2021-2026) & (K Units)
Figure 18. Respiratory Disease Vaccine Consumed in Pneumonia
Figure 19. Global Respiratory Disease Vaccine Market: Pneumonia (2021-2026) & (K Units)
Figure 20. Respiratory Disease Vaccine Consumed in Others
Figure 21. Global Respiratory Disease Vaccine Market: Others (2021-2026) & (K Units)
Figure 22. Global Respiratory Disease Vaccine Sale Market Share by Application (2025)
Figure 23. Global Respiratory Disease Vaccine Revenue Market Share by Application in 2026
Figure 24. Respiratory Disease Vaccine Sales by Company in 2026 (K Units)
Figure 25. Global Respiratory Disease Vaccine Sales Market Share by Company in 2026
Figure 26. Respiratory Disease Vaccine Revenue by Company in 2026 ($ millions)
Figure 27. Global Respiratory Disease Vaccine Revenue Market Share by Company in 2026
Figure 28. Global Respiratory Disease Vaccine Sales Market Share by Geographic Region (2021-2026)
Figure 29. Global Respiratory Disease Vaccine Revenue Market Share by Geographic Region in 2026
Figure 30. Americas Respiratory Disease Vaccine Sales 2021-2026 (K Units)
Figure 31. Americas Respiratory Disease Vaccine Revenue 2021-2026 ($ millions)
Figure 32. APAC Respiratory Disease Vaccine Sales 2021-2026 (K Units)
Figure 33. APAC Respiratory Disease Vaccine Revenue 2021-2026 ($ millions)
Figure 34. Europe Respiratory Disease Vaccine Sales 2021-2026 (K Units)
Figure 35. Europe Respiratory Disease Vaccine Revenue 2021-2026 ($ millions)
Figure 36. Middle East & Africa Respiratory Disease Vaccine Sales 2021-2026 (K Units)
Figure 37. Middle East & Africa Respiratory Disease Vaccine Revenue 2021-2026 ($ millions)
Figure 38. Americas Respiratory Disease Vaccine Sales Market Share by Country in 2026
Figure 39. Americas Respiratory Disease Vaccine Revenue Market Share by Country (2021-2026)
Figure 40. Americas Respiratory Disease Vaccine Sales Market Share by Type (2021-2026)
Figure 41. Americas Respiratory Disease Vaccine Sales Market Share by Application (2021-2026)
Figure 42. United States Respiratory Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 43. Canada Respiratory Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 44. Mexico Respiratory Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 45. Brazil Respiratory Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 46. APAC Respiratory Disease Vaccine Sales Market Share by Region in 2026
Figure 47. APAC Respiratory Disease Vaccine Revenue Market Share by Region (2021-2026)
Figure 48. APAC Respiratory Disease Vaccine Sales Market Share by Type (2021-2026)
Figure 49. APAC Respiratory Disease Vaccine Sales Market Share by Application (2021-2026)
Figure 50. China Respiratory Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 51. Japan Respiratory Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 52. South Korea Respiratory Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 53. Southeast Asia Respiratory Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 54. India Respiratory Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 55. Australia Respiratory Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 56. China Taiwan Respiratory Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 57. Europe Respiratory Disease Vaccine Sales Market Share by Country in 2026
Figure 58. Europe Respiratory Disease Vaccine Revenue Market Share by Country (2021-2026)
Figure 59. Europe Respiratory Disease Vaccine Sales Market Share by Type (2021-2026)
Figure 60. Europe Respiratory Disease Vaccine Sales Market Share by Application (2021-2026)
Figure 61. Germany Respiratory Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 62. France Respiratory Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 63. UK Respiratory Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 64. Italy Respiratory Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 65. Russia Respiratory Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 66. Middle East & Africa Respiratory Disease Vaccine Sales Market Share by Country (2021-2026)
Figure 67. Middle East & Africa Respiratory Disease Vaccine Sales Market Share by Type (2021-2026)
Figure 68. Middle East & Africa Respiratory Disease Vaccine Sales Market Share by Application (2021-2026)
Figure 69. Egypt Respiratory Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 70. South Africa Respiratory Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 71. Israel Respiratory Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 72. Turkey Respiratory Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 73. GCC Countries Respiratory Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Respiratory Disease Vaccine in 2026
Figure 75. Manufacturing Process Analysis of Respiratory Disease Vaccine
Figure 76. Industry Chain Structure of Respiratory Disease Vaccine
Figure 77. Channels of Distribution
Figure 78. Global Respiratory Disease Vaccine Sales Market Forecast by Region (2027-2032)
Figure 79. Global Respiratory Disease Vaccine Revenue Market Share Forecast by Region (2027-2032)
Figure 80. Global Respiratory Disease Vaccine Sales Market Share Forecast by Type (2027-2032)
Figure 81. Global Respiratory Disease Vaccine Revenue Market Share Forecast by Type (2027-2032)
Figure 82. Global Respiratory Disease Vaccine Sales Market Share Forecast by Application (2027-2032)
Figure 83. Global Respiratory Disease Vaccine Revenue Market Share Forecast by Application (2027-2032)
